During the past decade, Inje University Ilsan Paik Hospital conducted 39 clinical trials. In the 10-year time frame, 39 clinical trials started and 10 clinical trials were completed, i.e. on average, 25.6% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 5 clinical trials were completed. i.e. 35.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Inje University Ilsan Paik Hospital" #1 sponsor was "Pfizer" with 5 trials, followed by "Seoul National University Hospital" with 5 trials sponsored, "Boehringer Ingelheim" with 4 trials sponsored, "Inje University" with 4 trials sponsored and "Samsung Medical Center" with 4 trials sponsored. Other sponsors include 32 different institutions and companies that sponsored additional 34 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Inje University Ilsan Paik Hospital" #1 collaborator was "Inje University" with 6 trials as a collaborator, "Ulsan University Hospital" with 4 trials as a collaborator, "Inje University Ilsan Paik Hospital" with 3 trials as a collaborator, "Seoul National University Hospital" with 3 trials as a collaborator and "Chosun University Hospital" with 2 trials as a collaborator. Other collaborators include 28 different institutions and companies that were collaborators in the rest 35 trials.

According to Clinical.Site data, the most researched conditions in "Inje University Ilsan Paik Hospital" are "Coronary Artery Disease" (3 trials), "Ischemic Heart Disease" (3 trials), "Acute Ischemic Stroke" (2 trials), "Cardiovascular Disease" (2 trials) and "Chronic Kidney Disease" (2 trials). Many other conditions were trialed in "Inje University Ilsan Paik Hospital" in a lesser frequency.

Most popular intervention types in "Inje University Ilsan Paik Hospital" are "Drug" (41 trials), "Device" (6 trials), "Procedure" (4 trials), "Other" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Cilostazol" (2 trials), "YY-162" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "ASA 100 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Inje University Ilsan Paik Hospital" are 56 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Inje University Ilsan Paik Hospital". undefined are not yet recruiting, 5 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 32 completed trials in Inje University Ilsan Paik Hospital, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Inje University Ilsan Paik Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 12 trials, and there were also 6 trials that are defined as “Not Applicable".